Effect of estrogen on lipoprotein lipase activity and cytoplasmic progestin binding sites in lean and obese Zucker rats.
Injections of 5 micrograms estradiol benzoate (EB) for 5 days resulted in decreases in the rate of body weight gain in both lean (Fafa) and obese (fafa) Zucker rats. EB administration also resulted in significant induction of cytoplasmic progestin binding sites in both hypothalamic-preoptic area (H-POA) and adipose tissues from rats of both genotypes. However, EB treatment significantly decreased lipoprotein lipase (LPL) activity in adipose tissue from lean, but not obese, Zucker rats and the same treatment increased LPL activity in the uteri from lean, but not obese, Zucker rats. The data are discussed in terms of the metabolic and reproductive dysfunctions observed in the genetically obese rat.
D000273:Adipose Tissue / Q000201:enzymology / Q000378:metabolism; D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D003593:Cytoplasm / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D008071:Lipoprotein Lipase / Q000378:metabolism*; D009765:Obesity / Q000201:enzymology / Q000378:metabolism*; D011372:Progestins / Q000378:metabolism*; D051381:Rats; D014599:Uterus / Q000201:enzymology / Q000378:metabolism
D011372:Progestins; D004958:Estradiol; D008071:Lipoprotein Lipase